Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?

Autor: Silva de Lima UR; Post-graduation Program of Health Science, Federal University of Maranhão, São Luís, MA, Brazil., Vanolli L; Medicine Graduate Program, Federal University of Maranhão, São Luís, MA, Brazil., Moraes EC; Medicine Graduate Program, Federal University of Maranhão, São Luís, MA, Brazil., Ithamar JS; President Vargas Hospital, São Luís, MA, Brazil., Azevedo CMPES; Post-graduation Program of Health Science, Federal University of Maranhão, São Luís, MA, Brazil.; Department of Medicine, Federal University of Maranhão, São Luís, MA, Brazil.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2019 Dec 05; Vol. 14 (12), pp. e0225875. Date of Electronic Publication: 2019 Dec 05 (Print Publication: 2019).
DOI: 10.1371/journal.pone.0225875
Abstrakt: Background: The aim of this study was to compare cases of Visceral Leishmaniasis (VL) with and without HIV in a state in northeastern Brazil.
Methodology: We performed a comparative study in the state's referral hospital for infectious/parasitic diseases located in Northeast Brazil between January 2007 and July 2017. The data obtained using this protocol were analyzed with SPSS.
Principal Findings: In total, 252 patients were evaluated, including 126 with coincident VL/HIV and 126 with VL alone. Both groups primarily consisted of male patients. The most commonly affected ages were 30-39 years in the coinfected group and 19-29 years in the VL group (p < 0.001). Fever and anorexia (p = 0.001), which were more common in those with VL alone, were frequently observed, while diarrhea, vomiting, bleeding and dyspnea were more common in patients with VL/HIV coinfection (p<0.005). According to the hemogram results, leukocyte levels were lower in the VL group (p < 0.0001). Additionally, AST (aspartate aminotransferase) and ALT (alanine aminotransferase) levels differed between the groups, with higher levels in patients with VL (p < 0.001). On average, HIV was diagnosed 2.6 years before VL (p < 0.001), and VL relapse was observed only in the coinfection group (36.5% of cases). Fever (β = +0.17; p = 0.032) in the first VL/HIV episode was identified as a risk factor for relapse (R2 = 0.18). More deaths occurred in the VL/HIV group (11.1%) than in the VL group (2.4%).
Conclusion/significance: VL/HIV was found to be prevalent among young adults, although the median patient age was higher in the VL/HIV group. The classic symptomatology of VL was more common in patients not coinfected with HIV; therefore, attention is needed in patients with HIV who present with any symptoms that suggest the presence of VL, especially in endemic areas. No cases of VL relapse occurred in patients without HIV, and death was more common in the VL/HIV co-infected group.
Competing Interests: The authors have declared that no competing interests exist.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje